non tissue culture treated plate (TaKaRa)
96
Structured Review
TaKaRa
non tissue culture treated plate
Non Tissue Culture Treated Plate, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 473 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+tissue+culture+treated+plate/Culture+Plate/bio_rxiv__64898__2026__03__04__709574-114-4-13
Average 96 stars, based on 473 article reviews
Non Tissue Culture Treated Plate, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 473 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+tissue+culture+treated+plate/Culture+Plate/bio_rxiv__64898__2026__03__04__709574-114-4-13
Average 96 stars, based on 473 article reviews
non tissue culture treated plate - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Sterility:Article Title: Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo. Article Snippet: To activate the T cells, 2 days before transduction (Day 2), 24-well non-tissue culture-treated plates were coated with 0.5 mL per well of a 1 mg/mL cocktail of anti-human CD3 (clone HIT3a) and anti-human CD28 (clone CD28.2) from BioLegend each for 4 h. After this, each well was blocked with complete medium consisting of 223 mL of Click’s Medium from Irvine Scientific (Santa Ana, CA, USA), 222 mL of RPMI 1640 from Corning (Corning, NY, USA), 50 mL of heat-inactivated fetal bovine serum from Gibco (Waltham, MA, USA) and 5 mL of penicillin/streptomycin solution from Cytiva (Marlborough, MA, USA) for 30 minutes and 1 million HLA-A2 (negative) PBMCs were plated per well and incubated at 37°C overnight. .. The following day (Day 1), PBMCs were stimulated with 50 IU/mL rhIL-2 from R&D Systems (Minneapolis, MN, USA) and a separate 24-well Saline:Article Title: Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo. Article Snippet: To activate the T cells, 2 days before transduction (Day 2), 24-well non-tissue culture-treated plates were coated with 0.5 mL per well of a 1 mg/mL cocktail of anti-human CD3 (clone HIT3a) and anti-human CD28 (clone CD28.2) from BioLegend each for 4 h. After this, each well was blocked with complete medium consisting of 223 mL of Click’s Medium from Irvine Scientific (Santa Ana, CA, USA), 222 mL of RPMI 1640 from Corning (Corning, NY, USA), 50 mL of heat-inactivated fetal bovine serum from Gibco (Waltham, MA, USA) and 5 mL of penicillin/streptomycin solution from Cytiva (Marlborough, MA, USA) for 30 minutes and 1 million HLA-A2 (negative) PBMCs were plated per well and incubated at 37°C overnight. .. The following day (Day 1), PBMCs were stimulated with 50 IU/mL rhIL-2 from R&D Systems (Minneapolis, MN, USA) and a separate 24-well Incubation:Article Title: Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo. Article Snippet: To activate the T cells, 2 days before transduction (Day 2), 24-well non-tissue culture-treated plates were coated with 0.5 mL per well of a 1 mg/mL cocktail of anti-human CD3 (clone HIT3a) and anti-human CD28 (clone CD28.2) from BioLegend each for 4 h. After this, each well was blocked with complete medium consisting of 223 mL of Click’s Medium from Irvine Scientific (Santa Ana, CA, USA), 222 mL of RPMI 1640 from Corning (Corning, NY, USA), 50 mL of heat-inactivated fetal bovine serum from Gibco (Waltham, MA, USA) and 5 mL of penicillin/streptomycin solution from Cytiva (Marlborough, MA, USA) for 30 minutes and 1 million HLA-A2 (negative) PBMCs were plated per well and incubated at 37°C overnight. .. The following day (Day 1), PBMCs were stimulated with 50 IU/mL rhIL-2 from R&D Systems (Minneapolis, MN, USA) and a separate 24-well Article Title: Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer Article Snippet: .. T Cell Lentiviral Transduction and Culture After removal of immunomagnetic beads, 0.4-0.5×106 T cells/well of a Activation Assay:Article Title: cBAF complex components and MYC cooperate early in CD8 + T cell fate. Article Snippet: The identification of mechanisms to promote memory T (Tmem) cells has important implications for vaccination and anti-cancer immunotherapy.. Using a CRISPR-based screen for negative regulators of Tmem cell generation in vivo , here we identify multiple components of the mammalian canonical BRG1/BRM-associated factor (cBAF).. Several components of the cBAF complex are essential for the differentiation of activated CD8 T cells into T effector (Teff) cells, and their loss promotes Tmem cell formation in vivo. Article Title: Rapid metabolic regulation of a novel arginine methylation of KCa3.1 attenuates T cell exhaustion Article Snippet: Naive CD8 + T cells from 6–8 weeks old CD45.1 + mice were activated with plate-bound anti-CD3ε (1 μg/ml, 145-2C11, cat. BE0001, BioXcell), anti-CD28 (2 μg/ml, 37.51, cat. BE0015, BioXcell) and 50 U ml −1 rhIL-2 (cat. 200-02, Peprotech). .. On day 2 post activation, activated CD8 + T cells were transduced with retrovirus expressing B7-H3-CAR on retronectin-coated (cat. T100B, Transduction:Article Title: cBAF complex components and MYC cooperate early in CD8 + T cell fate. Article Snippet: The identification of mechanisms to promote memory T (Tmem) cells has important implications for vaccination and anti-cancer immunotherapy.. Using a CRISPR-based screen for negative regulators of Tmem cell generation in vivo , here we identify multiple components of the mammalian canonical BRG1/BRM-associated factor (cBAF).. Several components of the cBAF complex are essential for the differentiation of activated CD8 T cells into T effector (Teff) cells, and their loss promotes Tmem cell formation in vivo. Article Title: Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer Article Snippet: .. T Cell Lentiviral Transduction and Culture After removal of immunomagnetic beads, 0.4-0.5×106 T cells/well of a Article Title: Rapid metabolic regulation of a novel arginine methylation of KCa3.1 attenuates T cell exhaustion Article Snippet: Naive CD8 + T cells from 6–8 weeks old CD45.1 + mice were activated with plate-bound anti-CD3ε (1 μg/ml, 145-2C11, cat. BE0001, BioXcell), anti-CD28 (2 μg/ml, 37.51, cat. BE0015, BioXcell) and 50 U ml −1 rhIL-2 (cat. 200-02, Peprotech). .. On day 2 post activation, activated CD8 + T cells were transduced with retrovirus expressing B7-H3-CAR on retronectin-coated (cat. T100B, Article Title: Pathway incompatibility between NF-κB and RAS signaling constrains oncogenicity in B-cell leukemia Article Snippet: .. For retroviral transduction, the Expressing:Article Title: cBAF complex components and MYC cooperate early in CD8 + T cell fate. Article Snippet: The identification of mechanisms to promote memory T (Tmem) cells has important implications for vaccination and anti-cancer immunotherapy.. Using a CRISPR-based screen for negative regulators of Tmem cell generation in vivo , here we identify multiple components of the mammalian canonical BRG1/BRM-associated factor (cBAF).. Several components of the cBAF complex are essential for the differentiation of activated CD8 T cells into T effector (Teff) cells, and their loss promotes Tmem cell formation in vivo. Article Title: Rapid metabolic regulation of a novel arginine methylation of KCa3.1 attenuates T cell exhaustion Article Snippet: Naive CD8 + T cells from 6–8 weeks old CD45.1 + mice were activated with plate-bound anti-CD3ε (1 μg/ml, 145-2C11, cat. BE0001, BioXcell), anti-CD28 (2 μg/ml, 37.51, cat. BE0015, BioXcell) and 50 U ml −1 rhIL-2 (cat. 200-02, Peprotech). .. On day 2 post activation, activated CD8 + T cells were transduced with retrovirus expressing B7-H3-CAR on retronectin-coated (cat. T100B, Control:Article Title: cBAF complex components and MYC cooperate early in CD8 + T cell fate. Article Snippet: The identification of mechanisms to promote memory T (Tmem) cells has important implications for vaccination and anti-cancer immunotherapy.. Using a CRISPR-based screen for negative regulators of Tmem cell generation in vivo , here we identify multiple components of the mammalian canonical BRG1/BRM-associated factor (cBAF).. Several components of the cBAF complex are essential for the differentiation of activated CD8 T cells into T effector (Teff) cells, and their loss promotes Tmem cell formation in vivo. Plasmid Preparation:Article Title: Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer Article Snippet: .. T Cell Lentiviral Transduction and Culture After removal of immunomagnetic beads, 0.4-0.5×106 T cells/well of a Retroviral:Article Title: IL-7 armed binary CAR T cell strategy to augment potency against solid tumors Article Snippet: Cells were cultured in complete medium (RPMI-1640 containing 45% Clicks medium (Irvine Scientific, Inc., Santa Ana, CA), 10% FBS and 2 mM L-GlutaMAX), which was supplemented with recombinant human IL-2 (50 U/mL, NIH, Bethesda, VA) on day 1. .. On day 3 post OKT3/CD28 T blast generation, 1 mL of retroviral supernatant was added to a 24-well Article Title: Pathway incompatibility between NF-κB and RAS signaling constrains oncogenicity in B-cell leukemia Article Snippet: .. For retroviral transduction, the Recombinant:Article Title: IL-7 armed binary CAR T cell strategy to augment potency against solid tumors Article Snippet: Cells were cultured in complete medium (RPMI-1640 containing 45% Clicks medium (Irvine Scientific, Inc., Santa Ana, CA), 10% FBS and 2 mM L-GlutaMAX), which was supplemented with recombinant human IL-2 (50 U/mL, NIH, Bethesda, VA) on day 1. .. On day 3 post OKT3/CD28 T blast generation, 1 mL of retroviral supernatant was added to a 24-well Virus:Article Title: Pathway incompatibility between NF-κB and RAS signaling constrains oncogenicity in B-cell leukemia Article Snippet: .. For retroviral transduction, the Centrifugation:Article Title: Pathway incompatibility between NF-κB and RAS signaling constrains oncogenicity in B-cell leukemia Article Snippet: .. For retroviral transduction, the |